{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:56:44Z","timestamp":1776301004359,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003711","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["NSC98-2320-B-006-008-MY3"],"award-info":[{"award-number":["NSC98-2320-B-006-008-MY3"]}],"id":[{"id":"10.13039\/501100003711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003711","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["NSC101-2320-B-006-034"],"award-info":[{"award-number":["NSC101-2320-B-006-034"]}],"id":[{"id":"10.13039\/501100003711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003711","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["NSC102-2320-B-006-017"],"award-info":[{"award-number":["NSC102-2320-B-006-017"]}],"id":[{"id":"10.13039\/501100003711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003711","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["NSC98-2314-B-037-041-MY3"],"award-info":[{"award-number":["NSC98-2314-B-037-041-MY3"]}],"id":[{"id":"10.13039\/501100003711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003711","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["NSC101-2314-B-037-007-MY3"],"award-info":[{"award-number":["NSC101-2314-B-037-007-MY3"]}],"id":[{"id":"10.13039\/501100003711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["MOHW104-TDU-B-212-124-003"],"award-info":[{"award-number":["MOHW104-TDU-B-212-124-003"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Center for Infectious Disease and Cancer Research, Kaohsiung Medical University","award":["KMU-TP103 E19"],"award-info":[{"award-number":["KMU-TP103 E19"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.taap.2015.11.007","type":"journal-article","created":{"date-parts":[[2015,11,14]],"date-time":"2015-11-14T18:24:55Z","timestamp":1447525495000},"page":"98-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Histone deacetylase inhibitor trichostatin A resensitizes gemcitabine resistant urothelial carcinoma cells via suppression of TG-interacting factor"],"prefix":"10.1016","volume":"290","author":[{"given":"Bi-Wen","family":"Yeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Chia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Yi","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Nung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzyh-Chyuan","family":"Hour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-Miao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Jeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huei-Sheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2015.11.007_bb0005","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.critrevonc.2008.06.002","article-title":"Optimizing therapeutic strategies in advanced bladder cancer: update on chemotherapy and the role of targeted agents","volume":"69","author":"Bellmunt","year":"2009","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.taap.2015.11.007_bb0010","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.3390\/ijms13011186","article-title":"Inhibition of AKT2 enhances sensitivity to gemcitabine via regulating PUMA and NF-kappaB signaling pathway in human pancreatic ductal adenocarcinoma","volume":"13","author":"Chen","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2015.11.007_bb0015","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/carcin\/bgq110","article-title":"Genetic variations of the PI3K\u2013AKT\u2013mTOR pathway and clinical outcome in muscle invasive and metastatic bladder cancer patients","volume":"31","author":"Chen","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.taap.2015.11.007_bb0020","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.taap.2015.11.007_bb0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc745","article-title":"New functions for the matrix metalloproteinases in cancer progression","volume":"2","author":"Egeblad","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.taap.2015.11.007_bb0030","first-page":"4222","article-title":"Transforming growth factor beta1 treatment leads to an epithelial\u2013mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation","volume":"61","author":"Ellenrieder","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2015.11.007_bb0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0305-7372(96)90014-6","article-title":"Clinical, toxicological and pharmacological aspects of gemcitabine","volume":"22","author":"Guchelaar","year":"1996","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.taap.2015.11.007_bb0040","first-page":"639","article-title":"Gene alterations in the PI3K\/PTEN\/AKT pathway as a mechanism of drug-resistance (review)","volume":"40","author":"Hafsi","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.taap.2015.11.007_bb0045","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bcp.2011.03.026","article-title":"UBE2M-mediated p27(Kip1) degradation in gemcitabine cytotoxicity","volume":"82","author":"Huang","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2015.11.007_bb0050","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.freeradbiomed.2012.06.014","article-title":"TG-interacting factor-induced superoxide production from NADPH oxidase contributes to the migration\/invasion of urothelial carcinoma","volume":"53","author":"Huang","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.taap.2015.11.007_bb0055","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.taap.2009.12.037","article-title":"Blockage of JNK pathway enhances arsenic trioxide-induced apoptosis in human keratinocytes","volume":"244","author":"Huang","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2015.11.007_bb0060","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/j.juro.2011.06.053","article-title":"Induction of caspase mediated apoptosis and down-regulation of nuclear factor-kappaB and Akt signaling are involved in the synergistic antitumor effect of gemcitabine and the histone deacetylase inhibitor trichostatin A in human bladder cancer cells","volume":"186","author":"Jeon","year":"2011","journal-title":"J. Urol."},{"key":"10.1016\/j.taap.2015.11.007_bb0065","doi-asserted-by":"crossref","first-page":"7445","DOI":"10.1038\/sj.onc.1210546","article-title":"Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition","volume":"26","author":"Julien","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.taap.2015.11.007_bb0070","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10555-009-9198-3","article-title":"Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer","volume":"28","author":"Knowles","year":"2009","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.taap.2015.11.007_bb0075","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.juro.2013.09.031","article-title":"Prospective comparison of molecular signatures in urothelial cancer of the bladder and the upper urinary tract\u2014is there evidence for discordant biology?","volume":"191","author":"Krabbe","year":"2014","journal-title":"J. Urol."},{"key":"10.1016\/j.taap.2015.11.007_bb0080","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.eururo.2014.03.003","article-title":"A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma","volume":"66","author":"Leow","year":"2014","journal-title":"Eur. Urol."},{"key":"10.1016\/j.taap.2015.11.007_bb0085","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.eururo.2008.01.054","article-title":"Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients","volume":"54","author":"Li","year":"2008","journal-title":"Eur. Urol."},{"key":"10.1016\/j.taap.2015.11.007_bb0090","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1442-2042.2006.01344.x","article-title":"Histone deacetylase inhibitor trichostatin A inhibits the growth of bladder cancer cells through induction of p21WAF1 and G1 cell cycle arrest","volume":"13","author":"Li","year":"2006","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.taap.2015.11.007_bb0095","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11373-007-9232-9","article-title":"Inhibitory role of TGIF in the As2O3-regulated p21WAF1\/CIP1 expression","volume":"15","author":"Liu","year":"2008","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.taap.2015.11.007_bb0100","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1042\/BJ20101653","article-title":"Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells","volume":"438","author":"Liu","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.taap.2015.11.007_bb0105","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1517\/14728222.2011.566216","article-title":"Overcoming drug resistance in pancreatic cancer","volume":"15","author":"Long","year":"2011","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.taap.2015.11.007_bb0110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.urolonc.2013.08.029","article-title":"Highlights from the first symposium on upper tract urothelial carcinoma","volume":"32","author":"Matin","year":"2014","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.taap.2015.11.007_bb0115","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc1779","article-title":"Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer","volume":"6","author":"Minucci","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.taap.2015.11.007_bb0120","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1464-410X.2009.08795.x","article-title":"Inhibition of bladder tumour growth by histone deacetylase inhibitor","volume":"105","author":"Ozawa","year":"2010","journal-title":"BJU Int."},{"key":"10.1016\/j.taap.2015.11.007_bb0125","doi-asserted-by":"crossref","first-page":"10014","DOI":"10.1073\/pnas.180316197","article-title":"Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation","volume":"97","author":"Richon","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2015.11.007_bb0130","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.eururo.2013.03.032","article-title":"European guidelines on upper tract urothelial carcinomas: 2013 update","volume":"63","author":"Roupret","year":"2013","journal-title":"Eur. Urol."},{"key":"10.1016\/j.taap.2015.11.007_bb0135","first-page":"9","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.taap.2015.11.007_bb0140","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1200\/JCO.2001.19.3.666","article-title":"Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients","volume":"19","author":"Stein","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.taap.2015.11.007_bb0145","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1186\/1471-2407-12-354","article-title":"Human pancreatic adenocarcinoma contains a side population resistant to gemcitabine","volume":"12","author":"Van den Broeck","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.taap.2015.11.007_bb0150","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1200\/JCO.2005.07.757","article-title":"Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer","volume":"23","author":"von der Maase","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.taap.2015.11.007_bb0155","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.18632\/oncotarget.1471","article-title":"Chemoresistance to gemcitabine in hepatoma cells induces epithelial-mesenchymal transition and involves activation of PDGF-D pathway","volume":"4","author":"Wu","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.taap.2015.11.007_bb0160","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.3747\/co.v18i1.695","article-title":"First- and second-line therapy for metastatic urothelial carcinoma of the bladder","volume":"18","author":"Yafi","year":"2011","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.taap.2015.11.007_bb0165","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.ajpath.2012.05.024","article-title":"Overexpression of TG-interacting factor is associated with worse prognosis in upper urinary tract urothelial carcinoma","volume":"181","author":"Yeh","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.taap.2015.11.007_bb0170","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1464-410X.2010.09210.x","article-title":"Nuclear factor-kappaB activation predicts an unfavourable outcome in human upper urinary tract urothelial carcinoma","volume":"106","author":"Yeh","year":"2010","journal-title":"BJU Int."},{"key":"10.1016\/j.taap.2015.11.007_bb0175","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.juro.2010.10.034","article-title":"The histone deacetylase inhibitor trichostatin A synergistically resensitizes a cisplatin resistant human bladder cancer cell line","volume":"185","author":"Yoon","year":"2011","journal-title":"J. Urol."},{"key":"10.1016\/j.taap.2015.11.007_bb0180","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/bies.950170510","article-title":"Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function","volume":"17","author":"Yoshida","year":"1995","journal-title":"Bioessays"},{"key":"10.1016\/j.taap.2015.11.007_bb0185","first-page":"608","article-title":"Characterization of a newly established human bladder carcinoma cell line, NTUB1","volume":"91","author":"Yu","year":"1992","journal-title":"J. Formos. Med. Assoc."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X15301344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X15301344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:44:20Z","timestamp":1758573860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X15301344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":37,"alternative-id":["S0041008X15301344"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2015.11.007","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histone deacetylase inhibitor trichostatin A resensitizes gemcitabine resistant urothelial carcinoma cells via suppression of TG-interacting factor","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2015.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}